Elanco Animal Health (ELAN) Return on Capital Employed (2018 - 2026)

Elanco Animal Health (ELAN) has 9 years of Return on Capital Employed data on file, last reported at 5.24% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed rose 1195.0% year-over-year to 5.24%; the trailing twelve-month figure through Mar 2026 stood at 5.24% (up 1195.0% YoY), and the FY2025 full-year result was 4.9%, up 1735.0% from the prior year.
• Return on Capital Employed grew to 5.24% in Q1 2026, from 4.71% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 5.24% in Q1 2026 to a low of 26.01% in Q2 2024.
• A 5-year average of 12.25% and a median of 13.78% in 2023 frame the typical range for Return on Capital Employed.
• Across the five-year window, Return on Capital Employed tumbled 1255 bps in 2024 and surged 2580 bps in 2025, its largest moves.
• Tracing ELAN's Return on Capital Employed over 5 years: stood at 14.68% in 2022, then plunged by 62 bps to 23.84% in 2023, then soared by 45 bps to 13.02% in 2024, then soared by 136 bps to 4.71% in 2025, then rose by 11 bps to 5.24% in 2026.
• Business Quant data shows ELAN's Return on Capital Employed at 5.24% in Q1 2026, 4.71% in Q4 2025, and 0.41% in Q3 2025.